Dear Reader,

I am pleased to invite you to the third annual FierceBiotech Drug Development Forum (DDF). This year's conference is taking place in Boston, October 1–3, 2018 and is still the only event that covers the entire drug development process from basic research through clinical trials. Registration is available by clicking here.

Our all-new program features managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities — and much more. See below for a sample of some of our program panels and click here to view the full program.

• Innovate Value-Based Pricing Models for Long-Lasting Therapies
• Fine-Tune Biotech Priorities for Improving Diversity
• Combination Therapies for Immuno-Oncology
• Nurturing Relationships with VCs and Planning Financial Strategy
• Manage Partnerships and Portfolios to Survive the Next Market Downturn
• Specialize your CRO Outreach for Early Research
• Improve your Orphan Drug Strategy for Growth

And here are just a few of our confirmed speakers. Click here to view our full list of speakers.

• Andrew Allen, CEO, Gritstone Oncology
• Stephen Bancel, CEO, Moderna Therapeutics
• Roy Baynes, CMO, VP, Head of Clinical Development, Merck
• Barbara Dalton, VP, Venture Capital, Pfizer
• Robert Gould, CEO, Fulcrum Therapeutics
• Douglas Ingram, CEO, Sarepta Therapeutics
• Salim Mujais, Senior VP, Global Therapeutics Head, Specialty Pharma, Astellas
• Chandra Ramanathan, VP and Head, East Coast Innovation Center, Bayer
• Amrit Ray, Global President, R&D, PFIZER
• Martine Zimmerman, Senior VP, Global Regulatory Affairs, Alexion Pharmaceuticals

Don't miss this chance to attend this year's conference. I look forward to seeing you in Boston. Early bird rates expire August 17 so be sure to register soon.

Regards,

Rebecca Willumson
Publisher
FierceBiotech

—Sponsorship opportunities are still available. If you are interested in sponsoring DDF, please email Andrew Sinetar at asinetar@exlevents.com.

Want to reach 160,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.

About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets 1900 L St. NW Suite we 400  Washington, DC 20036